PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.40 -0.01 (-1.63%)
As of: Oct 1, 2026 · 3:59 PM EDT

PharmaCyte Biotech (PMCB) Debt Ratio (2011 - 2021)

Updated

PharmaCyte Biotech's (PMCB) Debt Ratio stood at 0.02 in fiscal Q3 2021 (quarter ended Jan 31, 2021), up 18.8% from the prior quarter.

Analysis

PharmaCyte Biotech (PMCB) Debt Ratio (2011 - 2021) Analysis & Trends

For FY2020 (ended Apr 30, 2020), PharmaCyte Biotech's Debt Ratio came in at 0.01.

  • The fiscal Q3 2021 figure is the highest quarterly Debt Ratio since fiscal Q2 2014.
  • Per Business Quant, the preceding three fiscal quarters came in at 0.01 (Q2 2021), 0.02 (Q1 2021) and 0.01 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 0.24
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 0.52
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 0.42
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 0.31
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 0.00
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 0.60
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 0.53
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 PharmaCyte Biotech 4.40 Mn 4.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2021 0.02
Oct 31, 2020 0.01
Jul 31, 2020 0.02
Apr 30, 2020 0.01
Jan 31, 2014 0.00
Oct 31, 2013 0.09
Jul 31, 2013 0.12
Apr 30, 2013 0.15
Jan 31, 2013 0.17
Oct 31, 2012 0.18
Jul 31, 2012 0.33
Apr 30, 2012 1.00
Jan 31, 2012 1.19
Oct 31, 2011 1.37
Jul 31, 2011 1.50
Apr 30, 2011 1.91
API Access

PharmaCyte Biotech Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=PMCB&period=max&api_key=YOUR_API_KEY